- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CAH
BUE
Week ended 24 Jul 2026
Weekly Investor Report
Cardinal Health, Inc. · Healthcare · Medical Distribution
Latest close
121,550 ARS
1.2%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 13.2% above the Trend Line and sits at 90.6% of its 52-week range. The latest completed week returned 1.2%, after a -0.0% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
58
out of 100
Latest Close
121,550 ARS
24 Jul 2026
1W Return
1.2%
latest completed week
4W Return
-0.0%
short-term follow-through
12W Return
25.5%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
0.2x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.2%
Latest completed week; four-week move -0.0%.
Indicator stack
59/82
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 56.86%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
22 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.2% above the Trend Line and sits at 90.6% of its 52-week range. The latest completed week returned 1.2%, after a -0.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4912-week average 0.43
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.49Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.0% over four weeks, 25.5% over 12 weeks, and 79.7% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.76Latest activity-pressure read.
Pressure change232.2%Four-week change in activity pressure.
Leadership2.40Latest relative-leadership reading.
RS change-72.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 22 relevant articles.
8 positive · 12 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.8%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher14 of 2612 weeks finished lower.
Best week+7.6%Week of 12 Jun.
Worst week-5.5%Week of 8 May.
Latest week+1.2%Week of 24 Jul.
Shape of recent returns
Strong gains6
Modest gains8
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.8%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAR Healthcare
4-week rank16 / 20
Group average4.0%
Trend breadth45.0%
Trend45.0%active weekly trend signals
MD80.0%positive activity pressure
RS35.0%positive relative leadership
Four-week leaders
IndustryAR Medical Distribution
4-week rank1 / 1
Group average0.0%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape57/100
Trend, activity pressure, participation, and risk combine to a 57/100 tape read.
Indicator analysis41/100Latest 12-week confirmation: trend 4/12, activity pressure 5/12, relative leadership 7/12.
Activity pressure 0.49; 2 reversal markers Next-Week ExpectancyPositive 56.86%Next-week expectancy is positive with a 56.86% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 22 relevant articles.
Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 121,550 ARS | 1.2% | 107,366 ARS | 61,835 ARS | 0.76 | 2.40 | 167 | On |
| 17 Jul 2026 | 120,075 ARS | -1.9% | 106,979 ARS | 61,162 ARS | 0.85 | 4.18 | 200 | On |
| 10 Jul 2026 | 122,350 ARS | 0.2% | 106,444 ARS | 60,499 ARS | 0.86 | 3.80 | 65 | On |
| 3 Jul 2026 | 122,050 ARS | 0.4% | 105,703 ARS | 59,823 ARS | 0.67 | 6.44 | 1.4K | On |
| 26 Jun 2026 | 121,597 ARS | 3.4% | 104,974 ARS | 59,144 ARS | 0.23 | 8.82 | 727 | Off |
| 19 Jun 2026 | 117,655 ARS | 6.0% | 104,524 ARS | 58,469 ARS | -0.32 | 0.25 | 14 | Off |
| 12 Jun 2026 | 110,997 ARS | 7.6% | 104,100 ARS | 57,816 ARS | -0.76 | -6.93 | 235 | Off |
| 5 Jun 2026 | 103,137 ARS | 6.0% | 103,805 ARS | 57,203 ARS | -1.02 | -5.86 | 1.2K | Off |
| 29 May 2026 | 97,275 ARS | -2.0% | 103,685 ARS | 56,635 ARS | -1.07 | -13.28 | 533 | Off |
| 22 May 2026 | 99,225 ARS | 2.3% | 103,624 ARS | 56,101 ARS | -0.98 | -1.40 | 793 | Off |
| 15 May 2026 | 97,000 ARS | 6.0% | 103,126 ARS | 55,554 ARS | -0.99 | 1.84 | 1.8K | Off |
| 8 May 2026 | 91,500 ARS | -5.5% | 102,563 ARS | 55,023 ARS | -1.02 | -5.54 | 4.0K | Off |
| 1 May 2026 | 96,825 ARS | -2.3% | 102,090 ARS | 54,521 ARS | -1.08 | -1.99 | 3.0K | Off |
| 24 Apr 2026 | 99,100 ARS | -4.7% | 101,480 ARS | 53,982 ARS | -1.14 | 0.44 | 820 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.